The genesis of high-throughput structure-based drug discovery using protein crystallography
- 25 October 2002
- journal article
- review article
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 6 (5) , 704-710
- https://doi.org/10.1016/s1367-5931(02)00361-7
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Accelerating code to function: sizing up the protein production lineCurrent Opinion in Chemical Biology, 2002
- High-Throughput Proteomics: Protein Expression and Purification in the Postgenomic WorldProtein Expression and Purification, 2001
- Design of high-throughput methods of protein production for structural biologyStructure, 2000
- Cool data: quantity AND qualityActa Crystallographica Section D-Biological Crystallography, 1999
- Rapid protein-folding assay using green fluorescent proteinNature Biotechnology, 1999
- Viracept (Nelfinavir Mesylate, AG1343): A Potent, Orally Bioavailable Inhibitor of HIV-1 ProteaseJournal of Medicinal Chemistry, 1997
- Influenza Neuraminidase Inhibitors Possessing a Novel Hydrophobic Interaction in the Enzyme Active Site: Design, Synthesis, and Structural Analysis of Carbocyclic Sialic Acid Analogues with Potent Anti-Influenza ActivityJournal of the American Chemical Society, 1997
- Crystal structure of HIV-1 protease in complex with VX-478, a potent and orally bioavailable inhibitor of the enzymeJournal of the American Chemical Society, 1995
- Rational design of potent sialidase-based inhibitors of influenza virus replicationNature, 1993
- Phase Determination by Multiple-Wavelength X-Ray Diffraction: Crystal Structure of a Basic "Blue" Copper Protein from CucumbersScience, 1988